Exact Mass: 652.2625

Exact Mass Matches: 652.2625

Found 22 metabolites which its exact mass value is equals to given mass value 652.2625, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Dehydroisocoproporphyrinogen

3-[15,20-bis(2-carboxyethyl)-19-(carboxymethyl)-10-ethenyl-5,9,14-trimethyl-21,22,23,24-tetraazapentacyclo[16.2.1.1³,⁶.1⁸,¹¹.1¹³,¹⁶]tetracosa-1(21),2,4,6,8(23),9,11,13,15,17,19-undecaen-4-yl]propanoic acid

C36H36N4O8 (652.2533)


Dehydroisocoproporphyrinogen is a member of the isocoproporphyrinogen family, a group that is excreted in only trace amounts in healthy humans, but up to 36\\% of porphyrins excreted in porphyria cutanea tarda. Formed from pentacarboxyporphyrinogen by coproporphyrinogen III oxidase (Biochem J. 1991 Jan 1;273(Pt 1):246-7). A member of the isocoproporphyrinogen family, a group that is excreted in only trace amounts in healthy humans, but up to 36\\% of porphyrins excreted in porphyria cutanea tarda. Formed from pentacarboxyporphyrinogen by coproporphyrinogen III oxidase (Biochem J. 1991 Jan 1;273(Pt 1):246-7) [HMDB]

   

aeruginosin IN652

aeruginosin IN652

C29H45BrN6O6 (652.2584)


   

Asp Phe Trp Trp

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-phenylethyl]carbamoyl}propanoic acid

C35H36N6O7 (652.2645)


   

Asp Trp Phe Trp

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-phenylethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C35H36N6O7 (652.2645)


   

Asp Trp Trp Phe

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C35H36N6O7 (652.2645)


   

Phe Asp Trp Trp

(3S)-3-[(2S)-2-amino-3-phenylpropanamido]-3-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C35H36N6O7 (652.2645)


   

Phe Trp Asp Trp

(3S)-3-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C35H36N6O7 (652.2645)


   

Phe Trp Trp Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]butanedioic acid

C35H36N6O7 (652.2645)


   

Trp Asp Phe Trp

(3S)-3-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-{[(1S)-1-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}-2-phenylethyl]carbamoyl}propanoic acid

C35H36N6O7 (652.2645)


   

Trp Asp Trp Phe

(3S)-3-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C35H36N6O7 (652.2645)


   

Trp Phe Asp Trp

(3S)-3-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-{[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]carbamoyl}propanoic acid

C35H36N6O7 (652.2645)


   

Trp Phe Trp Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]-3-(1H-indol-3-yl)propanamido]butanedioic acid

C35H36N6O7 (652.2645)


   

Trp Trp Asp Phe

(3S)-3-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}propanoic acid

C35H36N6O7 (652.2645)


   

Trp Trp Phe Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-3-phenylpropanamido]butanedioic acid

C35H36N6O7 (652.2645)


   

Dehydroisocoproporphyrin

Dehydroisocoproporphyrin

C36H36N4O8 (652.2533)


   

AZD3409

AZD3409

C34H41FN4O4S2 (652.2553)


   

Tazemetostat Hydrobromide

Tazemetostat Hydrobromide

C34H45BrN4O4 (652.2624)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C156804 - EZH2 Inhibitor

   

Dehydroisocoproporphyrinogen

Dehydroisocoproporphyrinogen

C36H36N4O8 (652.2533)


   

9-(dimethylamino)-1-(4-{[2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl]amino}-4-oxobutyl)-2,2,4,11,11-pentamethyl-2,11-dihydronaphtho[2,3-g]quinolinium perchlorate

9-(dimethylamino)-1-(4-{[2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)ethyl]amino}-4-oxobutyl)-2,2,4,11,11-pentamethyl-2,11-dihydronaphtho[2,3-g]quinolinium perchlorate

C34H41ClN4O7 (652.2664)


   

LPIP 16:0

LPIP 16:0

C25H50O15P2 (652.2625)


   

(2s,3as,6r,7as)-1-[(2r)-2-{[(2r)-3-(3-bromo-4-hydroxyphenyl)-1,2-dihydroxypropylidene]amino}-4-methylpentanoyl]-n-(4-carbamimidamidobutyl)-6-hydroxy-octahydroindole-2-carboximidic acid

(2s,3as,6r,7as)-1-[(2r)-2-{[(2r)-3-(3-bromo-4-hydroxyphenyl)-1,2-dihydroxypropylidene]amino}-4-methylpentanoyl]-n-(4-carbamimidamidobutyl)-6-hydroxy-octahydroindole-2-carboximidic acid

C29H45BrN6O6 (652.2584)


   

1-(2-{[3-(3-bromo-4-hydroxyphenyl)-1,2-dihydroxypropylidene]amino}-4-methylpentanoyl)-n-(4-carbamimidamidobutyl)-6-hydroxy-octahydroindole-2-carboximidic acid

1-(2-{[3-(3-bromo-4-hydroxyphenyl)-1,2-dihydroxypropylidene]amino}-4-methylpentanoyl)-n-(4-carbamimidamidobutyl)-6-hydroxy-octahydroindole-2-carboximidic acid

C29H45BrN6O6 (652.2584)